LOMBARD MED INC's ticker is EVAR and the CUSIP is G55598109. A total of 18 filers reported holding LOMBARD MED INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,000 | -41.7% | 15,800 | -28.9% | 0.00% | – |
| Q2 2017 | $12,000 | -33.3% | 22,234 | -1.4% | 0.00% | – |
| Q1 2017 | $18,000 | +28.6% | 22,550 | 0.0% | 0.00% | – |
| Q4 2016 | $14,000 | -36.4% | 22,550 | -4.5% | 0.00% | – |
| Q3 2016 | $22,000 | -24.1% | 23,605 | -11.4% | 0.00% | – |
| Q2 2016 | $29,000 | -12.1% | 26,641 | -15.7% | 0.00% | – |
| Q1 2016 | $33,000 | +32.0% | 31,618 | +72.8% | 0.00% | – |
| Q4 2015 | $25,000 | -55.4% | 18,295 | +15.8% | 0.00% | – |
| Q3 2015 | $56,000 | -20.0% | 15,800 | 0.0% | 0.00% | – |
| Q2 2015 | $70,000 | -91.9% | 15,800 | -92.7% | 0.00% | – |
| Q1 2015 | $869,000 | +743.7% | 215,700 | +1265.2% | 0.00% | – |
| Q4 2014 | $103,000 | -15.6% | 15,800 | 0.0% | 0.00% | – |
| Q3 2014 | $122,000 | +3.4% | 15,800 | -3.7% | 0.00% | – |
| Q2 2014 | $118,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 3,473,452 | $22,056,000 | 6.26% |
| Aisling Capital LLC | 886,363 | $5,761,000 | 0.87% |
| PURA VIDA INVESTMENTS, LLC | 336,025 | $2,184,000 | 0.80% |
| Verition Fund Management LLC | 29,902 | $194,000 | 0.04% |
| FIL Ltd | 786,997 | $5,116,000 | 0.02% |
| Invesco Ltd. | 6,317,851 | $41,066,000 | 0.02% |
| Spark Investment Management LLC | 12,400 | $78,000 | 0.01% |
| GLG Partners LP | 60,892 | $396,000 | 0.01% |
| Alyeska Investment Group, L.P. | 100,391 | $653,000 | 0.01% |
| MOORE CAPITAL MANAGEMENT, LP | 45,000 | $293,000 | 0.01% |